news

Shandong Tai ai Peptide Biotechnology Co., Ltd. was recently recognized as a provincial-level “Specialized, Refined, Distinctive, and Innovative” (SRDI) SME. This honor serves as industry-wide validation of the company’s commitment to specialized, refined, distinctive, and innovative development. With 29 years of deep expertise in the field of small-molecule bioactive peptides—and a focus on the R&D and production of peptide raw materials and foods for special dietary uses—Taiaipeptide Group successfully passed the specialized assessment by leveraging its robust technological capabilities and competitive advantages within this niche sector.

01 Specialized Development

In terms of specialized development, the company has long focused on the niche sector of bioactive peptides, establishing three standardized production bases in Hebei, Liaoning, and Shandong. It has built a complete industry chain—spanning from raw material extraction to finished specialized dietary products—with an annual output of over 5,000 tons of peptide powder and products exported to more than 40 countries.

02 Precision Manufacturing

Regarding precision manufacturing, the company holds multiple international quality certifications—such as ISO and FSSC—and implements meticulous management practices, including raw material traceability and segmented quality control. It offers customized ODM and OEM production solutions tailored to client needs, effectively addressing diverse requirements across various application scenarios.

Leveraging distinctive core strengths, the company has independently mastered three proprietary processes—full-material-chain extraction, single-substance isolation, and in-house enzymatic hydrolysis—to create a unique product portfolio that fills a gap in the domestic market for highly active functional peptides.

03 Innovation Capability

Innovation capability is the core pillar behind the company’s recognition. By continuously increasing R&D investment and collaborating with numerous universities, the company has secured multiple patents and achieved over 300 scientific research outcomes. Having previously been designated a “High-Tech Enterprise,” the company has now further solidified its credentials in the science and technology innovation hierarchy with this “Specialized, Refined, Distinctive, and Innovative” (SRDI) recognition.

Looking ahead, Tai Ai Peptide will use this honor as a new starting point to deepen its focus on the specialized bio-peptide sector, intensify efforts to achieve breakthroughs in core technologies, and expand into markets for foods for special medical purposes (FSMP) and health-oriented consumer products. Through this SRDI development path, the company aims to drive the quality improvement and upgrading of the domestic bio-health industry.

Tai Ai Peptide Group

Founded in 1997, Tai Ai Peptide Group has dedicated 29 years to scientific research in the field of peptides. Recognized as a high-tech enterprise and a registered manufacturer and exporter with Customs, the Group has evolved into a comprehensive enterprise integrating the R&D, production, sales, and service of peptide products. Leveraging robust domestic and international research capabilities, Taiaipeptide Group has mastered three core technologies—whole-substance chain extraction, single-substance isolation, and proprietary enzymatic hydrolysis. The Group holds numerous national invention and utility model patents and has collaborated with major domestic universities on clinical trials, resulting in over a hundred scientific research achievements. Focusing on full-industry-chain services for small-molecule peptides, the Group operates three major production bases in Langfang (Hebei), Dalian (Liaoning), and Heze (Shandong). Its diverse business portfolio spans food ingredients, pharmaceutical raw materials, health supplements, and foods for special medical or dietary purposes. The company provides comprehensive global solutions, including raw peptide powder, ODM, OEM, and brand agency services. Its annual production capacity for raw peptide powder exceeds 5,000 tons, with products exported to more than 40 countries and regions worldwide.